SCHEMBL6709153

SCHEMBL6709153

O=C(Nc1ccc(Cl)cc1-c1noc(=O)[nH]1)c1noc2cc(-c3ccccc3C(F)(F)F)ccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.43
HIF1A Q16665 4/20 0.43
GRIK1 P39086 1/20 0.39
ROCK1 Q13464 1/20 0.38
GRM5 P41594 1/20 0.38
CA12 O43570 1/20 0.37
CA9 Q16790 1/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
KMT2A Q03164 2/20 0.37
MAPT P10636 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
TSHR P16473 1/20 0.37
MEN1 O00255 1/20 0.37
XBP1 P17861 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
KIT P10721 1/20 0.37
KDR P35968 1/20 0.37
FLT3 P36888 1/20 0.37
STK33 Q9BYT3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6711801 0.94 HIF1A (0.43) EPHX2HIF1AGRIK1ROCK1GRM5
SCHEMBL6709925 0.90 EPHX2 (0.41) EPHX2HIF1AGRIK1ROCK1NPC1
SCHEMBL6707809 0.88 EPHX2 (0.40) EPHX2HIF1AROCK1NPC1RAB9A
SCHEMBL6710367 0.87 HIF1A (0.47) HIF1AGRIK1ROCK1KMT2AMEN1
SCHEMBL6710221 0.86 EPHX2 (0.43) EPHX2HIF1AROCK1GRM5CA12
SCHEMBL6709033 0.85 HIF1A (0.49) HIF1AGRIK1ROCK1GRM5KMT2A
SCHEMBL6707727 0.84 GRIK1 (0.37) EPHX2HIF1AGRIK1ROCK1NPC1
SCHEMBL6713252 0.83 HIF1A (0.61) HIF1AGRIK1ROCK1RAB9ASMN1; SMN2
SCHEMBL6710072 0.83 HIF1A (0.45) HIF1AGRIK1ROCK1KITKDR
SCHEMBL6709967 0.82 CETP (0.35) EPHX2HIF1AROCK1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 EPHX2 2941/4885HIF1A 296/4885GRIK1 3885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.